| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Akebia Therapeutics, Inc. | SVP, Chief Accounting Officer | Common Stock | 219,954 | $268,982 | $1.22 | 12 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics, Inc. | 12 May 2022 | 1 | $0 | 4 | SVP, Chief Accounting Officer | 16 May 2022, 16:04 |
| AKBA | Akebia Therapeutics, Inc. | 28 Feb 2022 | 3 | -$8,503 | 4 | SVP, Chief Accounting Officer | 02 Mar 2022, 20:12 |
| AKBA | Akebia Therapeutics, Inc. | 03 Jan 2022 | 1 | -$13,335 | 4 | SVP, Chief Accounting Officer | 05 Jan 2022, 15:11 |